LOS ANGELES, July 6, 2026 /PRNewswire/ — The DJS Law Group reminds investors of a class action lawsuit against ADMA Biologics, Inc. (“ADMA” or “the Company”) (NASDAQ: ADMA) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by…
Source: prnewswire
Country: United States